News - MedTech

Nuclera closes £57m Series C financing

Nuclera, a biotechnology company accelerating protein expression and purification workflows through ...

HealthTech & life sciences lead way for VC investment

Health and life sciences is one of the fastest growing sectors for UK venture capital, according to ...

Antiverse raises £3.5m to advance GenAI antibody design platform

Antiverse, a BioTech company designing antibodies for challenging targets, has added £3.5 million t...

Liverpool University spinout AI-Sight secures seven-figure funding

AI-Sight – a University of Liverpool AI diagnostic technology spinout based at Sci-Tech Daresbury ...

Univa seeks to treat growing problem of eating disorders

Univa Health has raised £1 million in a pre-seed investment round. The London firm has developed...

Purespring raises £80m to target kidney disease

Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of ...

River Capital exits Alderley Analytical to European firm

Bioanalytical services specialist Alderley Analytical has been acquired by Dutch firm Synexa Life Sc...

Inovus Medical unveils next-gen surgical training tech

Surgical training technology firm Inovus Medical has launched a suite of second-generation modules f...

World’s first graphene brain surgery performed in Manchester

The world’s first human graphene-based brain surgery procedure has been performed in Manchester. ...

Constructive Bio raises £43m ‘to turn living cells into biofactories’

Constructive Bio, a pioneering synthetic genomics company, has secured £43 million in the first clo...

Welsh startup closes £550k for wound-dressing tech

MedTech startup Corryn Biotechnologies Ltd has secured a £150,000 investment from British Design Fu...

‘Dialysis breakthrough’ BioTech raises further funds

Invizius – the Edinburgh-based BioTech company developing breakthrough treatments for patients on ...

Subscribe to our newsletter

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.